U.S. flag

An official website of the United States government

NM_000337.6(SGCD):c.494G>A (p.Arg165Gln) AND Autosomal recessive limb-girdle muscular dystrophy type 2F

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Feb 8, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000700991.8

Allele description [Variation Report for NM_000337.6(SGCD):c.494G>A (p.Arg165Gln)]

NM_000337.6(SGCD):c.494G>A (p.Arg165Gln)

Gene:
SGCD:sarcoglycan delta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q33.3
Genomic location:
Preferred name:
NM_000337.6(SGCD):c.494G>A (p.Arg165Gln)
HGVS:
  • NC_000005.10:g.156595043G>A
  • NG_008693.2:g.729700G>A
  • NM_000337.6:c.494G>AMANE SELECT
  • NM_001128209.2:c.491G>A
  • NM_172244.3:c.494G>A
  • NP_000328.2:p.Arg165Gln
  • NP_000328.2:p.Arg165Gln
  • NP_001121681.1:p.Arg164Gln
  • NP_758447.1:p.Arg165Gln
  • LRG_205t1:c.494G>A
  • LRG_205:g.729700G>A
  • LRG_205p1:p.Arg165Gln
  • NC_000005.9:g.156022053G>A
  • NM_000337.5:c.494G>A
  • NM_172244.2:c.494G>A
Protein change:
R164Q
Links:
dbSNP: rs727503423
NCBI 1000 Genomes Browser:
rs727503423
Molecular consequence:
  • NM_000337.6:c.494G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128209.2:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172244.3:c.494G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Autosomal recessive limb-girdle muscular dystrophy type 2F (LGMDR6)
Synonyms:
Limb-girdle muscular dystrophy, type 2F; Muscular dystrophy limb-girdle with delta-sarcoglyan deficiency; MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6
Identifiers:
MONDO: MONDO:0011028; MedGen: C1832525; Orphanet: 219; OMIM: 601287

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000829771Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 13, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003931859Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Feb 8, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Nothing to display

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000829771.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 165 of the SGCD protein (p.Arg165Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SGCD-related conditions. ClinVar contains an entry for this variant (Variation ID: 165234). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SGCD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV003931859.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024